Abeona Therapeutics Q1 2026 Earnings Preview
Source: SeekingAlpha
2026-05-12 14:05:54 ET
More on Abeona Therapeutics
- Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB
- Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point
- Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript
- Abeona targets activation of 7 QTCs for ZEVASKYN by end of 2026 as patient demand doubles
- Seeking Alpha’s Quant Rating on Abeona Therapeutics
Read the full article on Seeking Alpha
For further details see:
Abeona Therapeutics Q1 2026 Earnings Preview
Abeona Therapeutics Inc.
NASDAQ: ABEO
ABEO Trading
-5.44% G/L:
$5.565 Last:
290,617 Volume:
$5.78 Open:
ABEO Latest News
May 26, 2026 08:30:00 am
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
May 13, 2026 07:30:00 am
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
ABEO Stock Data
$282,066,034
45,791,700
6.07%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Cleveland
